Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.
about
Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?Emerging technologies in paediatric leukaemiaZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid MalignanciesCoordination of nutrient availability and utilization by MAX- and MLX-centered transcription networksMyeloid malignancies: mutations, models and managementGenetic signature of histiocytic sarcoma revealed by a sleeping beauty transposon genetic screen in miceCircRNAs in hematopoiesis and hematological malignanciesMicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemiaA framework for regularized non-negative matrix factorization, with application to the analysis of gene expression dataStem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromesMeasuring information flow in cellular networks by the systems biology method through microarray dataFunctional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALLIdentification of a predominant co-regulation among kinetochore genes, prospective regulatory elements, and association with genomic instabilityAnalyse multiple disease subtypes and build associated gene networks using genome-wide expression profiles.Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.InSilico DB genomic datasets hub: an efficient starting point for analyzing genome-wide studies in GenePattern, Integrative Genomics Viewer, and R/Bioconductor.Optimising parallel R correlation matrix calculations on gene expression data using MapReduce.Machine-learned cluster identification in high-dimensional data.Identification of expression patterns in the progression of disease stages by integration of transcriptomic data.Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemiaRegulatory network of GATA3 in pediatric acute lymphoblastic leukemiaHigh p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycleRoutine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples.DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission.Integrative genomics of chronic obstructive pulmonary disease.PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.Leukemia gene atlas--a public platform for integrative exploration of genome-wide molecular data.IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaSelective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia.The European LeukemiaNet: achievements and perspectives.Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patientsA six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemiaUsing digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias.Visualising the cross-level relationships between pathological and physiological processes and gene expression: analyses of haematological diseasesEvaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaClinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemiaFHL2 regulates hematopoietic stem cell functions under stress conditions
P2860
Q26738706-C7954002-BF0E-4E74-9DC6-487478BD23AEQ26770327-2C212E9A-5EC4-4824-B42C-85A801A4216FQ26770729-881E2F71-262E-4B5F-988F-06487DC5584EQ26853482-BBA97548-F9B9-4671-85A9-ED81A51C8B67Q27000577-AAF2F146-1B2B-4633-9D26-8350787C56F8Q27332453-6945CCA0-C57F-494F-848D-7350FAA48E1AQ28073658-EE928DCE-68F8-45D5-8DE3-EA061ABB8F54Q28241703-61474793-2184-41DF-9F48-073CEEB07339Q28278807-A0817B3B-42DB-4C9B-9553-B3BC013EBC93Q28302909-3C391900-50EA-4520-B4F8-726213326BAEQ28395330-184FBCBE-5505-496B-92AC-669B6ECF9C3FQ28475897-C59503FF-507E-4872-A6A9-701A7F0A123AQ28477417-5C7AF99B-0383-4E62-BF86-D23DAA96F120Q30488013-388EEDF1-A3D3-43B5-A936-D9D52AD4AA0EQ30536424-E77B926B-4266-4B0D-AB3E-69FFD0B9D94FQ30536439-BE1394B2-FA7C-4DE2-8C9F-9A8F24B1A8EBQ30867604-7C9592AB-226E-4BA5-85F0-44FFA5E27D1AQ31152226-1D50B098-EF5F-4132-BE4E-1208A2FF406EQ31160928-A1918BC1-5E60-422E-8C19-F79085C4D485Q33688934-5A391898-B045-40C5-AB80-3EACA05908EAQ33688989-EC051EB4-96CB-4519-B605-B254137C9380Q33740606-851B19C1-AAE2-4035-94FF-BB6A5DCF3F26Q33829399-13C5A8CB-2789-4ADA-944B-70FAFA484ED2Q34103991-1864AE53-29F4-4B43-8BAF-3381EB72B46BQ34144877-3010A387-C209-4585-997B-F66A1D3B0FE7Q34228412-5190BD68-B17D-4633-B8B3-8662368AF368Q34232677-89C7DD6A-89F3-411F-AE7F-3E0CDC4C940EQ34267963-51596CB6-2449-4426-B8B4-D152CA96B6B0Q34312209-FD64F346-DE2E-41BF-95EA-A0EEE12F8E68Q34358106-DA324B4E-DFB1-45C4-80AA-729638CDF572Q34392488-872FC07A-E297-4C66-B3B2-8A32259DFA6CQ34451619-DB5C9743-64C0-4942-8A8A-70B5014A4FBBQ34469099-AF16AAFD-FDC2-45A6-AF94-50F71C20C561Q34477517-4AEF1C30-6B15-4965-A9C8-0D321EB64F64Q34477671-3234BE2F-C2A0-4435-8BF9-E43D4A99959CQ34542542-F9A96803-F580-4546-9080-13D0BE685D12Q34542996-FE709E8F-976B-422B-86F7-4F12F2CC4273Q34612039-888C884B-2E85-49CA-9BFC-924B2F1E5044Q34755687-E41E3CA7-FD2C-436E-A007-3363BC3239C8Q35137904-04687E3D-A152-4BF9-8C32-4E739AC3478C
P2860
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Clinical utility of microarray ...... tions in Leukemia Study Group.
@en
type
label
Clinical utility of microarray ...... tions in Leukemia Study Group.
@en
prefLabel
Clinical utility of microarray ...... tions in Leukemia Study Group.
@en
P2093
P2860
P50
P356
P1476
Clinical utility of microarray ...... tions in Leukemia Study Group.
@en
P2093
Alexander Kohlmann
Allen E Yeoh
Amanda Gilkes
Jesus M Hernández
Laura Z Rassenti
Lothar Wieczorek
Marie-Christine Béné
P Mickey Williams
Peter R Papenhausen
Sabina Chiaretti
P2860
P304
P356
10.1200/JCO.2009.23.4732
P407
P577
2010-04-20T00:00:00Z